????? ?? ?? ? ??? ????????????? ????????????????? ??????????????????? gene in people relapsing just after cure Together with the BCL2 antagonist venetoclax. 66 Resistance to those brokers has actually been connected to these mutations in all over 70% of scenarios, While they usually are subclonal